# Evaluation of the Safety and Performance of the Very High Power-Short Duration QDOT

> **NCT04592497** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** AF ablation

## Key facts

- **NCT ID:** NCT04592497
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-15
- **Primary completion:** 2021-10-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04592497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04592497, "Evaluation of the Safety and Performance of the Very High Power-Short Duration QDOT". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04592497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*